149 related articles for article (PubMed ID: 10403280)
1. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Harada S; Yamamura M; Okamoto H; Morita Y; Kawashima M; Aita T; Makino H
Arthritis Rheum; 1999 Jul; 42(7):1508-16. PubMed ID: 10403280
[TBL] [Abstract][Full Text] [Related]
2. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients.
Hwang SY; Kim HY
Mol Cells; 2005 Apr; 19(2):180-4. PubMed ID: 15879699
[TBL] [Abstract][Full Text] [Related]
3. IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells.
Elshabrawy HA; Volin MV; Essani AB; Chen Z; McInnes IB; Van Raemdonck K; Palasiewicz K; Arami S; Gonzalez M; Ashour HM; Kim SJ; Zhou G; Fox DA; Shahrara S
Angiogenesis; 2018 May; 21(2):215-228. PubMed ID: 29327326
[TBL] [Abstract][Full Text] [Related]
4. Negative impact of Interleukin-9 on synovial regulatory T cells in rheumatoid arthritis.
Chakraborty S; Gupta R; Kubatzky KF; Kar S; Kraus FV; Souto-Carneiro MM; Lorenz HM; Kumar P; Kumar V; Mitra DK
Clin Immunol; 2023 Dec; 257():109814. PubMed ID: 37879380
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of lactate on synovial fibroblast and macrophage effector functions.
Pucino V; Nefla M; Gauthier V; Alsaleh G; Clayton SA; Marshall J; Filer A; Clark AR; Raza K; Buckley CD
Front Immunol; 2023; 14():1183825. PubMed ID: 37304267
[TBL] [Abstract][Full Text] [Related]
6. Regional analysis of p53 mutations in rheumatoid arthritis synovium.
Yamanishi Y; Boyle DL; Rosengren S; Green DR; Zvaifler NJ; Firestein GS
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10025-30. PubMed ID: 12119414
[TBL] [Abstract][Full Text] [Related]
7. Synovial single-cell heterogeneity, zonation and interactions: a patchwork of effectors in arthritis.
Schonfeldova B; Zec K; Udalova IA
Rheumatology (Oxford); 2022 Mar; 61(3):913-925. PubMed ID: 34559213
[TBL] [Abstract][Full Text] [Related]
8. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers.
Lugo JP; Saiyed ZM; Lau FC; Molina JP; Pakdaman MN; Shamie AN; Udani JK
J Int Soc Sports Nutr; 2013 Oct; 10(1):48. PubMed ID: 24153020
[TBL] [Abstract][Full Text] [Related]
9. Low dose native type II collagen prevents pain in a rat osteoarthritis model.
Di Cesare Mannelli L; Micheli L; Zanardelli M; Ghelardini C
BMC Musculoskelet Disord; 2013 Aug; 14():228. PubMed ID: 23915264
[TBL] [Abstract][Full Text] [Related]
10. Hydrolyzed collagen intake increases bone mass of growing rats trained with running exercise.
Takeda S; Park JH; Kawashima E; Ezawa I; Omi N
J Int Soc Sports Nutr; 2013 Aug; 10(1):35. PubMed ID: 23914839
[TBL] [Abstract][Full Text] [Related]
11. Effect of different intake levels of dietary protein and physical exercise on bone mineral density and bone strength in growing male rats.
Takeda S; Kobayashi Y; Park JH; Ezawa I; Omi N
J Nutr Sci Vitaminol (Tokyo); 2012; 58(4):240-6. PubMed ID: 23132307
[TBL] [Abstract][Full Text] [Related]
12. Recent progress toward biomarker identification in osteoarthritis.
De Ceuninck F; Sabatini M; Pastoureau P
Drug Discov Today; 2011 May; 16(9-10):443-9. PubMed ID: 21262380
[TBL] [Abstract][Full Text] [Related]
13. Safety and toxicological evaluation of undenatured type II collagen.
Marone PA; Lau FC; Gupta RC; Bagchi M; Bagchi D
Toxicol Mech Methods; 2010 May; 20(4):175-89. PubMed ID: 20170336
[TBL] [Abstract][Full Text] [Related]
14. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis.
Tong T; Zhao W; Wu YQ; Chang Y; Wang QT; Zhang LL; Wei W
Inflamm Res; 2010 May; 59(5):369-77. PubMed ID: 19862478
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.
Crowley DC; Lau FC; Sharma P; Evans M; Guthrie N; Bagchi M; Bagchi D; Dey DK; Raychaudhuri SP
Int J Med Sci; 2009 Oct; 6(6):312-21. PubMed ID: 19847319
[TBL] [Abstract][Full Text] [Related]
16. Clinical review of chondroitin sulfate in osteoarthritis.
Uebelhart D
Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
19. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial.
Kim LS; Axelrod LJ; Howard P; Buratovich N; Waters RF
Osteoarthritis Cartilage; 2006 Mar; 14(3):286-94. PubMed ID: 16309928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
